Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Crossover Experiments01:16

Crossover Experiments

3.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.7K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

306
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
306
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

399
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
399
Randomized Experiments01:13

Randomized Experiments

7.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.9K
Study Design in Statistics01:15

Study Design in Statistics

9.2K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Fire needling on dysphagia due to pseudobulbar palsy after stroke: a randomized controlled trial].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2020
Same author

Bayesian adaptive linearization method for phase I drug combination trials with dimension reduction.

Pharmaceutical statistics·2020
Same author

Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.

Clinical chemistry and laboratory medicine·2020
Same author

Successful treatment of metastatic colorectal cancer with synchronous <i>BRAF V600E</i> mutation and dMMR with BGB-A317.

Immunotherapy·2020
Same author

TTTCA Repeat Expansion of <i>SAMD12</i> in a New Benign Adult Familial Myoclonic Epilepsy Pedigree.

Frontiers in neurology·2020
Same author

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

Neuro-oncology·2020

Related Experiment Video

Updated: Sep 20, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from

Wen Zhang1, Zhiying Pan2, Ying Yuan3

  • 1Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Journal of Biopharmaceutical Statistics
|June 9, 2022
PubMed
Summary

This study introduces a Bayesian adaptive design for biosimilar trials, using historical data to reduce sample size and improve efficiency. The novel approach enhances clinical trial design for biosimilar development.

Keywords:
Adaptive borrowingBayesian adaptive designElastic priorRandomized trials

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Related Experiment Videos

Last Updated: Sep 20, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacoeconomics

Background:

  • Reference products have extensive historical data available on efficacy and characteristics.
  • Biosimilar development requires rigorous clinical trials to demonstrate similarity.

Purpose of the Study:

  • To develop a Bayesian adaptive design for randomized biosimilar clinical trials.
  • To leverage historical data from the reference product to improve trial efficiency.
  • To reduce the sample size required for biosimilar trials.

Main Methods:

  • A group sequential approach was employed for interim analyses.
  • Elastic meta-analytic-predictive (EMAP) prior methodology was used to borrow information from historical data.
  • Adaptive randomization ratios were implemented to balance arm sample sizes.

Main Results:

  • The proposed Bayesian adaptive design significantly reduced the sample size of the reference arm.
  • The design achieved comparable statistical power to traditional randomized clinical trials.
  • The methodology was applied to a biosimilar trial for breast cancer patients.

Conclusions:

  • Bayesian adaptive designs offer a more efficient approach to biosimilar clinical trials.
  • Leveraging historical data through methods like EMAP can optimize resource allocation.
  • This design facilitates the development and approval of biosimilars.